glp 1 gaining weight Study finds GLP-1 receptor agonists target fat over muscle for loss GLP-1 based drugs: Could Elon

Glucagon-like peptide-1 (GLP-1) is an incretin known for its anti-obesity effects, and several effective drugs targeting GLP-1 receptors (GLP-1Rs) have recently been developed to treat obesity

New in FY2027 GLP-1 Medication Coverage for the Treatment of Obesity Coverage for GLP-1 medications prescribed for the treatment of obesity only, under GIC health plans, will end at the end of...

Discover how peptides like GLP-1 agonists, CJC-1295, and AOD-9604 can support weight loss by boosting metabolism, reducing hunger, and burning fat.

Beyond the Digital Health track of CES 2025, theres a food-tech agenda sponsored by The Spoon

Survey shows links to lower substance use and better impulse control.

Explore the implications of proposed changes to GLP-1 medication coverage and their impact on Medicare and Medicaid health plans